1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(3-PHENYL)-PROPANIMIDE
Compound with spectra: 1 NMR
![1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(3-PHENYL)-PROPANIMIDE](/api/compound/EbJrNXnlGct.png?ph=true&h=300&w=458 "1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(3-PHENYL)-PROPANIMIDE")
| SpectraBase Compound ID | EbJrNXnlGct |
|---|---|
| InChI | InChI=1S/C27H28ClN5O/c1-33(31-26(34)14-11-20-7-3-2-4-8-20)17-15-32(16-18-33)27-22-9-5-6-10-23(22)29-24-13-12-21(28)19-25(24)30-27/h2-10,12-13,19,29H,11,14-18H2,1H3 |
| InChIKey | QDMLFUXVZQIYOT-UHFFFAOYSA-N |
| Mol Weight | 474.01 g/mol |
| Molecular Formula | C27H28ClN5O |
| Exact Mass | 473.198238 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(4-PHENYL)-BUTANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(6-PHENYL)-HEXANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(8-PHENYL)-OCTANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(5-PHENYL)-PENTANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(10-PHENYL)-DECANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-2-(PHENYL)-ACETIMIDE
Clozapine-M (7 OH)
JHU37160
Clozapine-M (6 OH)
Clozapine ME
| Title | Journal or Book | Year |
|---|---|---|
| Aminimides as Potential CNS Acting Agents. II Design, Synthesis, and Receptor Binding of 4′-Arylalkyl Aminimide Analogues of Clozapine as Prospective Novel Antipsychotics | Australian Journal of Chemistry | 2008 |